CHE Staff publications archive

Staff in CHE publish frequently, including contributing to journals, books and commissioned reports. Archived publications are listed by year.

2010

  • Ashby R, Bland JM, Cullum N, Dumville J, Hall J, Kang'ombe A, Madden M, O'Meara S, Soares M, Torgerson D, Watson J. Reflections on the recommendations of the EWMA patient outcome group. Journal of Wound Care 2010;19(7):282-85. Download from Pubmed
  • Bailey H, Kind P. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Quality of Life Research 2010;19(8):1145-54.
  • Barbieri M, Drummond M, Rutten F, Cook J, Glick H, Lis J, Reed SD, Sculpher M, Severens J. On behalf of the ISPOR good research practices economic data transferability task force. What do international pharmacoeconomic guidelines say about economic data transferability? Value in Health 2010;13:1028-37.
  • Bloudek L, Spackman DE, Sullivan SD. A comparison of transitions between health states and institutionalization among alzheimer's disease patients versus non-alzheimer's disease dementia patients using the nacc-uds database. Value in Health 2010;13(3):108-9.
  • Bojke L, Claxton K, Bravo Vergel Y, Sculpher M, Palmer S, Abrams K. Eliciting distributions to populate decision analytic models. Value in Health 2010;13:557-64. Download from Wiley interscience
  • Campbell JD, Spackman DE. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy 2010;65(9):1141-48.
  • Carr-Hill R. The poor may always be with us; but we don’t know how many there are or where they are. Journal of Health Services Research and Policy 2010;15:121-130.
  • Carr-Hill R, Roberts F, Currie E. Approaches to costing adult literacy programmes, especially in Africa. International Journal of Educational Development 2010;30:428-37.
  • Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, Sculpher M, Eastwood A. Glycopeptide versus non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect 2010;11(5):455-62.
  • Chuang LH, Kind P. The Effect of Health State Selection on the Valuation of EQ-5D. Medical Decision Making 2010;31(1):186-194.
  • Cookson R, Culyer AJ.  Measuring overall population health - the use and abuse of QALYs, in Killoran A, Kelly M (eds). Evidence based public health: effectiveness and efficiency, Oxford: Oxford University Press, 2010, 148-168.
  • Cookson R, Dusheiko M, Hardman G, Martin S. Competition and inequality: evidence from the English national health service 1991-2001. Journal of Public Administration Research and Theory 2010;20:181-205.
  • Cox H, Tilbrook H, Aplin J, Chuang LH, Hewitt C, Jayakody S, Semlyen A, Soares M, Torgerson DJ, Trewhela A, Watt I, Worthy G. A pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocol. Complementary Therapies for Clinical Practice 2010;16(2):76-80. Download from Elsevier
  • Culyer AJThe dictionary of health economics. 2nd Edition, Cheltenham: Edward Elgar, 2010.
  • Culyer AJ. Perspective and desire in comparative effectiveness research - the relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics 2010;28:889-97.
  • Elliot RA, Weatherly HLAHawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2010;11(1):57-66. Download from springerlink
  • Fabbri D, Robone S. The geography of hospital admission in a National Health Service with patient choice: evidence from Italy. Health Economics 2010;19(9):1029-47.
  • Goddard MGravelle H, Hole A, Marini G. Where did all the GPs go? Increasing supply and geographical equity in England and Scotland. Journal of Health Services Research and Policy. 2010;15(1):28-35. Download from sage.
  • Gohel MS, Epstein D, Davies AH. Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg 2010;97(12):1815-23. Download from pubmed
  • Gomes M, Soares MO, Dumville J, Lewis SC, Torgerson D, Bodenham A.R, Gough MJ, Warlow CP and the GALA collaborative group. Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial). British Journal of Surgery 2010;97(8):1218-1225. Download from BJS
  • Gravelle H, Sutton M, Ma A. Doctor behaviour under a pay for performance contract: treating, cheating and case finding? Economic Journal 2010;120:F129-F56.
  • Griffin SClaxton K, Welton N. Exploring the research decision space: the expected value of information for sequential research designs. Medical Decision Making 2010;30:155-62. Download from Sage journals
  • Gutacker N, Neumann A, Santosa F, Moysidis T, Kroeger K. Amputations in PAD patients - data from the German federal statistical office. Vascular Medicine 2010;15:9-14.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. Breaking down the wall of silence around children affected by AIDS in Thailand to support their psychosocial health. Aids Care 2010;22:308-13.
  • Kristensen T, Laudicella M, Ejersted C, Street A. Cost variation in diabetes care delivered in English hospitals. Diabetic Medicine 2010;27(8):949-57.
  • Jones AM, Rice N, Roberts J. Early retirement among men in Britain and Germany: how important is health? The Geneva papers on risk and insurance: issues and practice (Special issue on health and ageing) 2010;35:644-67.
  • Jones AM, Rice NRosa-Dias P. Quality of schooling and inequality of opportunity in health. Health, Econometrics and Data Group (HEDG), University of York 2010;10/22.
  • Jones AM, Rice NRosa-Dias P. Long-term effects of cognitive skills, social adjustment and schooling on health and lifestyle: Evidence from a reform of selective schooling. Health Economics and Data Group (HEDG), University of York Working Paper 2010;10/11.
  • Jones AM, Rice N, Robone S, Rosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Health Economics and Data Group (HEDG), University of York working Paper 2010;10/27.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Health Econometrics and Data Group(HEDG), University of York 2010;10/05.
  • Laudicella M, Olsen KR, Street A. Examining cost variation across hospital departments - a two-stage multilevel approach using patient level data. Social Science and Medicine 2010;71(10):1872-1881.
  • Luce B, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. (The International Working Group for HTA Advancement ) EBM, HTA and CER: clearing the confusion. The Millbank Quarterly 2010;88:256-76.
  • Manca A, Eldabe S, Buchser E, Kumar K, Taylor RS. Relationship between health related quality of life, pain and functional disability in neuropathic pain patients with failed back surgery syndrome. Value in Health. 2010;13(1):95-102.
  • Manca A, Sculpher M, Goeree R. The analysis of multinational cost effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 2010;28:1079-96.
  • Marks L, Cave S, Hunter DJ, Mason JM, Peckham S, Wallace A, Mason AWeatherly H, Melvin K. Public health governance and primary care delivery: a triangulated study. final report; NIHR Service Delivery and Organisation programme 2010. Full Report and Executive Summary
  • Mason A, Drummond M, Ramsey S, Campbell J, Raisch D. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? Journal of Clinical Oncology 2010;28(20):3234-38.
  • Mason AStreet AVerzulli R. Private sector treatment centres are treating less complex patients than the NHS. Journal of the Royal Society of Medicine 2010;103:322-31.
  • Maund E, McKenna C, Sarowar M. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Health Technology Assessment 2010;14:Suppl.2. Download from pubmed
  • McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N, Abrams K. Continuing the multiple sclerosis risk sharing scheme is unjustified. British Medical Journal 2010;340(C1786) Download from BMJ
  • McKenna C , Burch J, Suekarran S. Aldosterone antagonists for post-myocardial infarction heart failure. Health Technology Assessment 2010;14(24):161.
  • McKenna C, Chalabi Z, Epstein DClaxton K. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. Journal of Health Economics 2010;29(1):170–181. Download from Science Direct
  • McKenna CHawkins NClaxton K, McDaid C, Suekarran S, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Cost-effectiveness of Enhanced External Counterpulsation (EECP) for the treatment of stable angina in the UK. International Journal of Technology Assessment in Health Care 2010;26(2):175-82. Download from Pubmed
  • McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer disease severity. Alzheimer's & Dementia 2010;6(6):482-03.
  • Neumann PJ, Drummond MF, Jonsson B, Luce BR, Schwartz JS, Siebert U, Sullivan S. Are key principles for improved health technology assessment supported and used by health technology assessment organizations? International Journal of Technology Assessment in Health Care 2010;26:71-78.
  • Norman G, Soares M, Peura P, Rice S, Suh D, Wright K, Sculpher M, Eastwood A. Capecitabin for advanced gastric cancer. Health Technology Assessment 2010;14(s2). Download from  Pubmed
  • Paton F, Paulden M, Saramago P, Manca A, Misso K, Palmer S, Eastwood A. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. Health Technology Assessment, 2010;14(S1):55-62.
  • Pattenden J, Mason ABetter Together: An end of life initiative for patients with heart failure and their families. M123S: Executive summary. British Heart Foundation, London. June 2010. Download from BHF
  • Pattenden J, Mason ABetter Together: An end of life initiative for patients with heart failure and their families. M123R: Final Report. British Heart Foundation, London. June 2010. Download from BHF
  • Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M. Alitretinoin for the treatment of severe chronic hand eczema. Health Technology Assessment 2010;14(s1):39-46. Download from NIHR
  • Pichon-Riviere A, Augustovski F, Rubinstein A, Marti SG, Sullivan SD, Drummond M. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? International Journal of Technology Assessment in Health Care2010;26:421-27.
  • Pridmore P, Carr-Hill R. Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed? Public Health Nutrition 2010;19:1-6.
  • RESPECT Trial Team. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. British Journal of General Practice. 2010;60:21-27.
  • Rice N, Robone S, Smith PC. International comparison of public sector performance: the use of anchoring vignettes to adjust self-reported data. Evaluation 2010;16:81-101.
  • Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Wollacott N, Sculpher M. Alitretinoin for severe chronic hand eczema: A NICE single technology appraisal. Pharmacoeconomics 2010;28(5):351-62. Download from Pubmed
  • Scheller-Kreinsen D, Geissler EA, Street A, Busse R. Leistungsbewertung von deutschen krankenhäusern - stärken, schwächen und vergleichbarkeit der bekannten methoden. Gesundh ökon Qual manag 2010;15:1-11.
  • Schut FT, Van den Berg B. Sustainability of comprehensive universal long-term care insurance in the Netherlands. Social Policy and Administration 2010;44:411-35.
  • Sculpher M, Claxton K. Sins of omission and obfuscation: IQWiG’s guidelines on economic evaluation methods. Health Economics 2010;19(10):1132-36.
  • Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, Drummond MF. Evidence synthesis, economics and public policy. Research Synthesis Methods 2010;1:126-135.
  • Spilsbury K, Adamson J, Atkin K, Bloor K, Carr-Hill R, McCaughan D, McKenna H, Wakefield A. Challenges and opportunities associated with the introduction and development of assistant practitioners supporting the work of ward-based registered nurses in acute NHS trusts in England. Journal of Health Services Research and Policy 2010;Supplement.
  • Spilsbury K, Bloor K, Bartlett C, Bonsanquet K, Carr-Hill R. Assistant practitioners: identity, responsibilities and development. British Journal of Healthcare Assistants 2010;4:599-602.
  • Street A. Letter in response to articles on Choice and Competition. Health Economics, Policy and Law 2010;5(2):247.
  • Street A, Scheller-Kreinsen D, Geissler A, Busse R. Determinants of hospital costs and performance variation: methods, models and variables for the EuroDRG project. Working Papers in Health Policy and Management 2010;Vol.3 May:Berlin: Universitätsverlag der TU Berlin. Download from eurodrg
  • The United Kingdom EVAR trial investigators. Endovascular versus open repair of abdominal aortic aneurysm. New England Journal of Medicine 2010;362:1863-71. Download from NEJM
  • The United Kingdom EVAR trial investigators. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. New England Journal of Medicine 2010;362:1872-80. Download from NEJM
  • Vitikainen K, Linna M, Street A. Substituting inpatient for outpatient care: what is the impact on hospital costs and efficiency? European Journal of Health Economics 2010;11(4):395-404.Download from springerlink
  • Wailoo AJ, Goodacre S, Sampson F, Hernandez M, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder MA, Gray H. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project. Heart 2010;96:668-72.
  • Walker SMason AClaxton KCookson R, Fenwick E, Fleetcroft R, Sculpher M. Value for money and the quality and outcomes framework in primary care in the NHS. British Journal of General Practice 2010;60(574):352-57. Download from BJGP
  • Walker D, Teerawattanonon Y, Anderson R, Richardson G. Generalisability, transferability, complexity and relevance. In: Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, editors. Evidence-based decisions and economics: health care, social welfare, education and criminal justice, 2nd Edition: Wiley-Blackwell; 2010.
  • Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, Richardson G, Lovell K, Dunn G. A randomised controlled trial of a nurse-led home-based self-help treatment for patients in primary care with chronic fatigue syndrome - the FINE trail. BMJ 2010;340:C1777.
  • Weatherly HMason A, Goddard M, Wright K. Financial integration across health & social care: evidence review. Scottish Government Social Research; 2010.

2009

  • Augustovski F, Iglesias CManca A, Drummond M, Rubinstein A, Garcia Marti S. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics 2009;27(11):919-29.
  • Austin PC, Manca A, Zwarenstein M, Juurlink DN, Stanbrook MB. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. Journal of Clinical Epidemiology, 2009;63(2):142-153.
  • Barbieri M, Hawkins NSculpher MJ. Who does the numbers? The role of third-party technology assessments to inform health systems' decision-making about the funding of health technologies. Value in Health. 2009;12:193-201.
  • Bojke L, Claxton K, Sculpher M, Palmer S . Characterizing structural uncertainty in decision-analytic models: a review and application of methods. Value in Health. 2009;12:739-49.
  • Bowyer S, Caraher M, Elbert K, Carr-Hill R. Shopping for food: lessons from a London borough. British Food Journal 2009;11:453-73.
  • Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):537-45.
  • Burch J, Epstein D, Baba-Akbari Sari A, Weatherly H, Jayne D, Fox D et al. Stapled haemorrhoidopexy for the treatment of haemorrhoids: a systematic review. Colorectal Disease. 2009;11:233-44.
  • Burch J, McKenna C, Palmer S, Norman G, Glanville J, Sculpher M, Woolacott N. Rimonabant for the treatment of overwieght and obese people. Health Technology Assessment 2009:13(Suppl3);3. Download from HTA
  • Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton N, Ades AE, Sutton A, Cooper N, Elliot A, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009;13(58):1-290. Download from HTA
  • Carr-Hill R . Data monitoring and evaluation, annex F. mid-term evaluation of the EFA fast track initiative 2009.
  • Carr-Hill R , Mason A, Street ANICE Guidance on Cost Effectiveness of Community Engagement to Improve Health; 2009.
  • Castelli A, Jacobs R, Goddard M, Smith P . Geographical variation in quality of life: The role of public service organisations. Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Castelli A, Jacobs R, Goddard M. Exploring the impact of public services on quality of life indicators: Public Services Programme: Quality, Performance & Delivery, Discussion Paper DP0902 2009.
  • Castelli A, Laudicella M, Street A, Ward P. Getting out what we put in (PDF , 224kb)‎ how productive is the NHS in England? Paper presented at the Health Economic Study Group Meeting. Sheffield 22-24 July 2009.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. The challenges of developing cost-effective public health guidance: a NICE perspective. In: Dawson S, Morris ZS, editors. Future public health: burdens, challenges and opportunities. Basingstoke: Palgrave Macmillan; 2009. p.276-91.
  • Chambers D, Epstein D, Walker S, Fayter D, Paton F, Wright K, et al. Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model. Health Technology Assessment 2009;13(48).
  • Chuang LH, Zarate V, Kind P. Estimating domestic values for EQ-5D health states using survey data from external sources. Medical Care 2009;47(2):168-75.
  • Conti S, Claxton K . Dimensions of design space: a decision theoretic approach to optimal research portfolio design. Medical Decision Making 2009;29:643-60. Download from Sage Journals online
  • Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, Nunn AJ, Manca ASculpher M et al. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin-treated diabetes (MITRE Study). Diabetic Medicine 2009;26(5):540-7. Download from Wiley InterScience
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Economics Policy and Law. 2009;4(2):231-45.
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Reply to Richardson and Shiell. Health Economics Policy and Law.2009;4(2):261-263.
  • Cookson R, Laudicella MDo the poor still cost more? The relationship between small area income deprivation and length of stay for elective hip replacement in the English NHS from 2001/2 to 2006/7. Health Economics and Data Group (HEDG), University of York Working Paper 09/07 2009.
  • Culyer AJHealth, distribution and fairness - sorting out the theory and matching it to future policy practice (notes for the Select Committee on Health) House of Commons Select Committee on Health, 3rd Report:Health Inequalities;2009.
  • Culyer AJDeliberative processes in decisions about health care technologies: combining different types of evidence, values, algorithms and people. London: Office of Health Economics; 2009.
  • Culyer AJ. How nice is NICE? A conversation with Anthony Culyer, Health Care Cost Monitor, 2009 Hastings Centre Blog.
  • Dixon J, Asaria P, Georghiou T, Billings J, Gravelle H, Martin S, Rice N, Smith P, Wennberg D, DeLorenzo M, Siegal M, Russell R, Filipova N. Developing a person based resource allocation formula for general practices in England. Report to the Department of Health; October 2009.
  • Dobrow MJ, Chafe R, Burchett HED, Culyer AJ, Lemieux-Charles L. Designing deliberative methods for combining heterogeneous evidence: A systematic review and qualitative scan. A report to the Canadian Health Services Research Foundation. Ottawa; 2009.
  • Drummond M , Barbieri M, Cook J, Glick H, Lis J, Malik F, Reed S, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR Good Practices Task Force report. Value in Health. 2009;12:409-18.
  • Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E. Consensus Development Group (2009) Toward a consensus on the QALY. Value in Health 2009;12(Suppl1):S31-35.
  • Dumville JC, Soares M. The economics of clinical decision making. In: Essential Decision Making and Clinical Judgement for Nurses. London: Churchill Livingstone; 2009.
  • Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares M, Torgerson DJ. VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. British Medical Journal 2009;Mar 19:338:b773. Download from BMJ
  • Dumville JC, Worthy G, Soares M, Bland JM, Cullum N, Dowson C, Iglesias C, McCaughan D, Mitchell JL, Nelson EA, Torgerson DJ. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers: Health Technology Assessment 2009 Nov;13(55):1-182, i-iv. Download from HTA
  • Elliot RA, Weatherly HLAHawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2009;11(1):57-66. Download from springerlink
  • Epstein D. Is EVAR worth the price difference? In: Greenhalgh R, editor. Vascular and Endovascular Controversies Update 31. London:Biba Medical;2009.
  • Epstein D. Opportunity Cost. In: Encyclopedia of Medical Decision Making. Sage Publications; 2009.
  • Epstein D, Bojke L, Sculpher M & the REFLUX trial group. The cost-effectiveness of laparoscopic fundoplication versus medical management for gastro oesophageal reflux disease. British Medical Journal 2009;338:b2576.
  • Epstein D, Jimenez Rubio D, Smith PC, Suhrcke M. Social determinants of health: an economic perspective. Health Economics 2009;18:495-502.
  • Gauthier A, Manca A, Anton S. Bayesian modelling of healthcare resource use in multinational randomised clinical trials. Pharmacoeconomics 2009;27(12):1017-1029.
  • Goddard M, Jacobs R. Using composite indicators to measure performance in health care. In: Smith PC, Mossialos E, Leatherman S, Papanicolas I, editors. Performance Measurement for Health System Improvement: experiences, challenges and prospects. Cambridge:Cambridge University Press;2009.Chapter 3.4. 
  • Goddard M, Mason A. Mental health learning points (PDF , 63kb)Healthcare Finance 2009 (November);pp39,41.
  • Gravelle H, Sutton M. Income, relative income, and self-reported health in Britain 1979-2000. Health Economics 2009;18(2):125-45.
  • Gravelle H, Sivey P. Imperfect quality information in a quality-competitive hospital market. Department of Economics and Related Studies (DERS), University of York Discussion Paper 2009;09/09.
  • Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgeway JP, Sculpher M, Ball SG, Plain S. Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Trials 2009;10:p62 (doi:10.1186/745-6215-10-62).
  • Griffin S , Dunn G, Palmer S, Macfarlane S, Brent S, Dyker A, et al. The use of paclitaxel in the management of early stage breast cancer. Health Technology Assessment 2009;13(s1):15-22.
  • Griffin S, Rice N, Sculpher M. Economic evaluation of public health interventions. In: Killoran A, Kelly M, editors. Evidence-based public health: effectiveness and efficiency. Oxford:Oxford University Press;2009.
  • Griffin S, Walker S, Sculpher M, et al. Cetuximab plus radiotherapy for the treatment of locally advance squamous cell carcinmoa of the head and neck. Health Technology Assessment 2009;13(s1):49-54. Download from HTA
  • Hann M, Goudie R, Sutton M, Gravelle H, Sibbald B. The Fifth National GP Worklife Survey. Final Report to Department of Health; June 2009.
  • Hewitt C, Gilbody S, Brealey S, Paulden M, Palmer S, Mann R, Green J, Morrell J, Barkham M, Light K, Richards D. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technology Assessment 2009;13(36):1-145,47-230. Download from HTA
  • Hoomans T, Fenwick E, Palmer S, Claxton K. Value of information and value of implementation: application of a framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value in Health 2009;12:315-24. Download from wiley InterScience
  • Hvenegaard A, Street A, Sørensen TH, Gyrd-Hansen D. Comparing hospital costs: what is gained by accounting for more than a case-mix index? Social Science & Medicine 2009;69:640-47.
  • Iglesias CManca A, Torgerson D. The health related quality of life and cost implications of falls in elderly women. Osteoporosis International 2009;Jun20(6):869-78.
  • Jacobs R. Which services improve our quality of life? Britain in 2010 magazine 2009:39.
  • Jacobs R, Castelli A, Goddard M, Smith PC. Impact of public services on quality of life indicators? LariaNews, LARIA Newsletter, Local Authorities Research Intelligence Association 2009.
  • Jacobs R, Chaloupka F, Tauras J, Water H. Taxation and the economics of tobacco control. In: Samet JM, Yoon SY, editors. Women and the Tobacco Epidemic: Challenges for the 21st century. Geneva: WHO; 2009.
  • Jacobs R, Street AFinal report: Efficiency analysis of PFI schemes: Report for the National Audit Office, November, pp34;2009.
  • Jacobs R, Street AThe relative efficiency of services delivered through hospital PFI contracts: feasibility study, Report for the National Audit Office York, Centre for Health Economics:14pp;2009.
  • Laudicella M, Cookson R, Jones AM, Rice N. Health care deprivation profiles in the measurement of inequality and inequity: an application to GP fundholding in the English NHS. Journal of Health Economics 2009;28(6):1048-61. Download from Sciencedirect
  • Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value in Health 2009;12(8):1187-93.
  • Manca A. Economic evaluation of medical devices and drugs - same or different? (Editorial). Value in Health 2009;12(4):401.
  • Manca A. Task force report on good research practices on economic data transferability in HTA (Editorial). Value in Health 2009;12(4):407.
  • Mannion R, Harrison S, Jacobs R, Konteh F, Walsh K, Davies HTO. From cultural cohesion to rules and competition: the trajectory of senior management culture in English NHS hospitals, 2001-2008. Journal of the Royal Society of Medicine 2009;102:332-36.
  • Mannion R, Street A. Managing activity and expenditure in the new NHS market: evidence from South Yorkshire. Public Money and Management 2009;29(1):27-34. Download from Taylor and Francis
  • Marini G, Miraldo M. Economies of scale and scope in the English hospital sector. Imperial College Business School Discussion Papers, 2009/05.
  • Martin S, Dusheiko M, Gravelle H, Rice N. Estimating needs for programme budget areas. Report to the Department of Health; December 2009.
  • McDaid C, Duree KH, Griffin SC, Weatherly HLA, Stradling JR, Davies RJO, Sculpher MJ, Westwood ME. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Medicine Reviews 2009;13(6):427-36. Details from Sleep Medicine Reviews 
  • McDaid C, Griffin S, Weatherly H, Duree KH, Burgt van der M, Hout van S, Akers J, Davies RJO, Sculpher M, Westwood M. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technology Assessment. 2009;13(4)pp1-142.
  • McKenna C, Bojke L, Manca A, et al. Shoulder acute pain in primary healthcare: Is retraining GP's effective (SAPPHIRE) randomised trial - cost effectiveness analysis. Rheumatology 2009;48:558-563.
  • McKenna C, McDaid C, Suekarran S, Hawkins NClaxton K, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Enhanced external counterpulsation (EECP) for the treatment of stable angina and heart failure: A systematic review and economic analysis. Health Technology Assessment 2009;13(24):1-112. Download from HTA
  • McKenna C, Palmer S , Rodgers M, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the UK. Heart 2009;95:542-9. Download from BMJ
  • Mason A, Street A, Miraldo M, Siciliani L. Should prospective payments be differentiated for public and private healthcare providers? Health Economics, Policy and Law. 2009;4(4):383-403. Download from Cambridge journals.
  • Newman SP, Cooke D, Casbard A, Walker S, Meredith S, Nunn A, Steed L, Manca ASculpher M, et al. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment. 2009;May;13(28):iii-iv, ix-xi,1-194.
  • Pridmore P, Carr-Hill RAddressing the underlying and basic causes of child undernutrition in developing countries: what works and why?” for DANIDA;2009.
  • Richardson G, Bloor K, Williams J, Russell I, Durai D, Cheung W-Y, et al. Cost-effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) BMJ 2009;338:b270.
  • Richardson G, Bojke C, Kennedy A, Reeves D, Bower P, Lee V et al. What outcomes are important to patients with long term conditions? A discrete choice experiment. Value in Health 2009;12(2):331-9.
  • Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis. Health Technology Assessment. 2009;13(31):1-77. Download from HTA
  • Santana P, Santos R, Nogueira H. The link between local environment and obesity: a multilevel analysis in the Lisbon Metropolitan Area, Portugal. Social Science & Medicine 2009;68(4):601–609.
  • Sculpher MJ, Lozano-Ortaga G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, et al. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. American Heart Journal 2009;157:845-52.
  • Siciliani L. Paying for performance and motivation crowding out. Economics Letters 2009;103:68-71.
  • Siciliani LGravelle H. Third degree waiting time discrimination: optimal allocation of a public sector healthcare treatment under rationing by waiting. Health Economics. 2009;18:977-86.
  • Siciliani L, Stanciole A, Jacobs R. Do waiting times reduce hospitals' costs? Journal of Health Economics 2009;28(4):771-80.
  • Siciliani LVerzulli R. Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE. Health Economics 2009;18(11):1295-306.
  • Soares M, Iglesias CP , Bland JM, Cullum N, Dumville JC, Nelson EA, Torgerson DJ, Worthy G. VenUS II team. Cost effectiveness analysis of larval therapy for leg ulcers British Medical Journal 2009 Mar;19:338:b825 doi:10.1136/bmj.b825. Download from BMJ
  • Smith PCGoddard M. The English National Health Service: an economic health check. Report for Organisation for Economic Co-operation and Development ECO/WKP58 July; 2009.
  • Spilsbury K, Stuttard L, Adamson J, Atkin K, Borglin G, McCaughan D, McKenna H, Wakefield A, Carr-Hill R. Mapping the introduction of assistant practitioner roles in acute NHS (hospital) trusts in England. Journal of Nursing Management 2009;17:615-26.
  • Street A, Hakkinen U. Health system productivity and efficiency. In: Smith PC, Mossialos E, Leatherman S, Papanicolas IN, editors. Performance measurement for health system improvement: experiences, challenges and prospects. World Health Organisation; 2009.
  • Street A, Laudicella MIdentifying inefficiency (PDF , 415kb): Why do costs differ from one hospital to another? Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Taylor RS, Iglesias CP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value in Health 2009;Jun 12(4):404-6.
  • Vallejo-Torres L, Morris S, Carr-Hill R, Dixon P, Law M, Rice N, Sutton M. Can regional resource shares be based only on prevalence data? an empirical investigation of the proportionality assumption. Social Science Medicine 2009;69:1634-42.
  • Vitikainen KStreet A, Linna M. Estimation of hospital efficiency - do different definitions and casemix measures for hospital output affect the results? Health Policy 2009;89:149-59.
  • Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane S, White S, Thomas S. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. Health Technology Assessment 2009;13(sl):35-40. Download from HTA
  • Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Sculpher M, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy 2009;93:85-92. Download from Elsevier 
  • Weatherly HLA, Griffin S, McDaid C, Duree KH, Davies RJO, Stradling JR, Sculpher MJ et al. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. International Journal of Technology Assessment in Health Care. 2009;25(01):26-34.
  • Williams J, Russell I, Durai D, Cheung W-Y, Farrin A, Bloor K, Coulton S, Richardson G. Effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) British Medical Journal. 2009;338:b231.

2008

  • Al-Ruzzeh S, Epstein D, George S, Bustami M, Wray J, Ilsley C, Sculpher M, Amrani M. Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. Artificial Organs 2008;32(11):891-7. Download from Wiley InterScience
  • Bansback N, Sun H, Guh D, Li X, Nosyk B, Griffin S et al. The impact of using a recall period on the measurement of health utilities for acute events. Health Economics 2008;17(12):1413-1419.
  • Bojke L, Claxton K, Sculpher M, Palmer S, Philips Z. The cost-effectiveness and value for information associated with repeat screening for age related macular degeneration. Medical Decision Making 2008;28:33-43. Download from Sage Journals Online
  • Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Practical Neurology 2008;8:175-82. Download from BMJ
  • Brouwer WBF, Culyer AJ, Job N, van Exel A, Rutten FFH. Welfarism vs. extra-welfarism. Journal of Health Economics 2008;27:325-38.
  • Burch J, Epstein D, Baba-Akbari A, Weatherly H, Fox D, Golder S, Jayne D, Drummond M, Woolacott N. Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technology Assessment 2008;12(8). Download from HTA
  • Chalabi Z, Epstein D, McKenna C, Claxton K. Uncertainty and value of information when allocating resources within and between healthcare programmes. European Journal of Operational Research 2008;191(2):530-9. Download from Science Direct
  • Chalkidou K, Culyer AJ, Littlejohns P, Doyle P, Hoy A. Imbalances in funding for clinical and public health research in the UK: can NICE research recommendations make a difference? Evidence and Policy 2008;4:355-69.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. Cost-effective public health guidance: asking questions from the decision-maker's viewpoint. Health Economics 2008;17:441-8.
  • Chalkidou K, Walley T, Culyer AJ, Littlejohns P, Hoy A. Evidence-informed evidence making. Journal of Health Services Research and Policy 2008;13:167-73.
  • Chauhan D, Mason A. Factors affecting the uptake of new medicines in secondary care - a literature review. Journal of Clinical Pharmacy and Therapeutics 2008;33(4):339-48.
  • Cheraghi-Sohi S, Hole A, Mead N, McDonald R, Whalley D, Bower P, et al. What do patients want from a primary care consultation: A stated preference discrete choice experiment to identify patient priorities. Annals of Family Medicine 2008;6(107-115).
  • Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008;9:781-98.
  • Claxton K, Briggs A, Buxton M, Culyer A, McCabe C, Walker SSculpher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008;336:251-4. Download from BMJ
  • Claxton K, Culyer A. Not a NICE fallacy: A reply to Dr Quigley. Journal of Medical Ethics 2008;34:598-601. 
  • Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.  A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.  Health Technology Assessment 2008;12:1-168.
  • Culyer AJ, Amick B, LaPorte A. What is a little more health and safety worth? In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford:Oxford University Press 2008:15-35.
  • Culyer AJ, Tompa E. Equity. In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:215-31.
  • Culyer A, Sculpher M. Lessons from health technology assessment. In:Tompa E, Culyer A, Dolinschi R, eds. Economic Evaluation of Interventions for Occupational Health and Safety. Oxford:Oxford University Press 2008.
  • Doran T, Fullwood C, Gravelle H, Reeves D, Roland M. Should physicians be allowed to exclude individual patients from pay for performance targets? Analysis of exception reporting in the UK pay for performance scheme. New England Journal of Medicine. 2008;359;274-284.
  • Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellance in the United Kingdom: A game of two halves? International Journal of Technology Assessment in Health Care 2008;24:146-50. Download from Cambridge Journals
  • Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ. Key principles for the improved conduct of health technology assessments for resource allocation decisions. International Journal of Technology Assessment in Health Care 2008;24(3):244-58.
  • Drummond M, Weatherly H, Ferguson B. Economic evaluation of health interventions: a broader perspective is needed that include potential cost and benefits for all stakeholders. British Medical Journal 2008;337:a1204.
  • Dusheiko M, Goddard M, Gravelle H, Jacobs R. Explaining trends in concentration of health care commissioning in the English NHS. Health Economics 2008;17(8):907-26. Download from Wiley Inter Science
  • Epstein DM, Garcia Mochon L. The accuracy of telemedicine compared with conventional methods in the diagnosis of malignant melanoma of the skin. Revista Espanola de Economia de la Salud 2008;7:193-6.
  • Epstein D, Sculpher M, Clayton T, Henderson R, Pocock SJ, Buxton M, et al. Costs of an early intervention versus a conservative strategy in acute coronary syndrome. International Journal of Cardiology 2008;127(2):240-6. Download from ScienceDirect
  • Epstein D, Sculpher M, Manca A, Michaels J, Thompson SG, Brown LC, et al. Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. British Journal of Surgery 2008;95:183-90.
  • Epstein D, Mason A, Manca A. The hospital costs of care for stroke in nine European countries. Health Economics 2008;17 (S1):S21-S31. Download from Wiley inter science
  • Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Medical Decision Making 2008;28:21-32. Download from Sage Journals Online
  • Golder S, Mason A, Spilsbury K. Systematic searches for the effectiveness of respite care. Journal of the Medical Library Association 2008;96(2):147-52.
  • Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M , et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technology Assessment 2008;12(31):1-204.
  • Gravelle H, Morris S, Sutton M. Are family physicians good for your health? Endogenous supply and health. Health Services Research 2008;43(4):1128-1144.
  • Gravelle H, Siciliani L. Optimal quality, waits and charges in health insurance. Journal of Health Economics 2008;27(3):663-74.
  • Gravelle HSiciliani L. Is waiting-time prioritisation welfare improving? Health Economics 2008;17:167-85.
  • Gravelle H, Siciliani L. Ramsey waits: allocating public health service resources when there is rationing by waiting. Journal of Health Economics 2008;27(5):1143-54.
  • Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. Journal of Health Services Research and Policy 2008;13:23-30. Download from RSM Press
  • Griffin S, Weatherly H, Richardson G, Drummond M. Methodological issues in undertaking independant cost-effectiveness analysis for NICE: the case of therapies for ADHD. The European Journal of Health Economics 2008;9(2):137-45.
  • Henriksson M, Epstein D, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, et al. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart 2008;94:717-23. Download from BMJ
  • Hicks L, Gibbs I, Weatherly H, Byford S. Management, leadership and resources in children's homes: what influences outcomes in residential child-care settings? British Journal of Social Work 2008;39(5):828-845. Download from Oxford Journals
  • Hurley J, Pasic D, Lavis J, Culyer AJ, Mustard C, Gnam W. Parallel payers and preferred access: how Canada's workers' compensation boards expedite care for injured and ill workers. HealthcarePapers 2008;8:6-14.
  • Hurley J, Culyer AJ, Gnam W, Lavis J, Mustard C, Pasic D. Response to commentaries. HealthcarePapers 2008;8:52-4.
  • Hurley J, Pasic D, Lavis J, Mustard C, Culyer AJ, Gnam W. Parallel lines do intersect: interactions between the workers' compensation and provincial publicly financed health care systems in Canada. Health Care Policy 2008;3:100-12.
  • Manca A, Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, Taylor RJ, Goeree R, Sculpher MJ. Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain 2008;12:1047-58.
  • Manesh AO, Sheldon TA, Pickett KE, Carr-Hill R. Accuracy of child morbidity data in demographic and health surveys. International Journal of Epidemiology 2008;37:194-200. 
  • Mannion R, Marini G, Street A. Implementing payment by results in the English NHS: changing incentives and the role of information. Journal of Health Organization and Management 2008;22(1):79-88.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Giving greater financial independence to hospitals - does it make a difference? the case of English NHS Trusts. Health Economics 2008;17(6):751-75.
  • Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. Journal of Health Economics 2008;27(4):826-42.
  • Mason A. New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics 2008;33:1-10.
  • Mason ACarr-Hill R, Myers L, Street A. Establishing the economics of engaging communities in health promotion: what is desirable, what is feasible? Critical Public Health 2008;18(3):285-97.
  • Mason ARDrummond M. NHS Reimbursement of new cancer drugs: is NICE getting nastier? (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008). Value in Health 2008;11(3):A11.
  • Mason A, Walker S, Claxton K, Cookson R, Fenwick E, Sculpher MThe GMS quality and outcomes framework (PDF , 238kb) : Are the quality and outcomes framework (QOF) indicators a cost-effective use of NHS resources? In: Quality and Outcomes Framework. Joint executive summary: Reports to the Department of Health from the University of East Anglia and the University of York. 
  • McCabe C, Claxton K, O'Hagan A. Why licensing authorities need to consider the net value of new drugs - addressing the tension between licensing and reimbursement. International Journal of Technology Assessment in Health Care 2008;24:140-5. Download from Cambridge Journals
  • McCabe C, Culyer A, Claxton K. The NICE cost-effectiveness threshold: what it is and what it means. Pharmacoeconomics 2008; 9:733-44.
  • Morris S, Gravelle H. GP supply and obesity. Journal of Health Economics 2008;27(5):1357-67.
  • Olry de Labry Lima A, Sordo del Castillo L, Garcia Mochon L, Epstein D, Bermudez C, Villegas R. Evaluacion economica de la prueba genetica de la poliposis adenomatosa familiar. Rev Esp Enfirm Dig 2008;100(8):470-5.
  • Olsen KR, Street A. The analysis of efficiency among a small number of organisations:how inferences can be improved by exploiting patient-level data. Health Economics 2008;17(6):671-81. Download from Wiley
  • Phillips Z, Claxton K, Palmer S. The half-life of truth? what is the appropriate time horizons for research decisions? Medical Decision Making 2008;28:287-99. Download from Sage Journals Online
  • Reeves D, Kennedy A, Fullwood C, Bower P, Gardner C, Gately C, Lee V, Richardson G, Rogers A. Predicting who will benefit from an expert patients programme self-management course. British Journal of General Practice 2008;58(548):198-203.
  • Richardson G, Kennedy A, Reeves D, Bower P, Lee V, Middleton E, et al. Cost-effectiveness of the expert patient programme (EPP) for patients with chronic conditions. Journal of Epidemiology and Community Health 2008;62:361-367.
  • Rodgers M, McKenna C, Palmer S, et al. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technology Assessment 2008;12(34). Download from HTA
  • Rogers A, Kennedy A, Reeves D, Bower P, Lee V, Gardner C, Gately C, Richardson G. The UK expert patients programme: results and implications from a national evaluation. Medical Journal of Australia 2008;Nov17:189(10 Suppl):S21-4.
  • Ryan M, Griffin S, Chitah B, Walker SA, Mulenga V, Kalolo D, Hawkins N, Sculpher MJ, et al. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. Aids 2008;22:749-57.
  • Sculpher MJ. NICE's 2008 methods guide: sensible consolidation or opportunities missed? Pharmacoeconomics 2008;26:721-4.
  • Sculpher MJ. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008;26:799-806.
  • Soares M, Dumville JC. Critical appraisal of cost-effectiveness and cost-utility studies in health care. Evidence Based Nursing 2008;11(4):99-102. Download from BMJ
  • Soares M, Dumville JC. Economic evaluation of healthcare technologies using primary research. Evidence Based Nursing  2008;11(3):67-71. Download from BMJ
  • Spiby H and the ELSA team. Improving care at the primary/secondary interface: a trial of community-based support in early labour (ELSA). Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO). November 2008. Download from NIHR
  • Tompa E, Culyer AJ, Dolinschi R. Suggestions for a reference case. In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:235-44.
  • Tompa E, Culyer AJ, Dolinschi R, (Eds). Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008.
  • Whalley D, Gravelle H, Sibbald B. Impact of the new general medical services contract on general practitioners' job satisfaction and perceptions of quality of care in the UK. British Journal of General Practice 2008;58:8-14.
  • Zarate V, Kind P, Chuang LH. Hispanic valuation of the EQ-5D health states: A social value set for Latin Americans. Value in Health 2008;11(7):1170-77.

2007

  • Asseburg C, Bravo Vergel Y, Palmer S, Fenwick E, de Belder M, Abrams A, Sculpher M. Assessing the effectiveness of primary angioplasty compared to thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart 2007;93:1244-50. Download from BMJ
  • Bansback N, Maetzel A, Drummond MF, Anis A, Marra C, Conway P, Tugwell P, Boers M, Boonen A. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis. The Journal of Rheumatology 2007;34(5):1178-83.
  • Bojke L, Hornby E, Sculpher M; on behalf of the REFLUX Trial Team. A comparison of the cost effectiveness of pharmacotherapy or surgery (Laporoscopic Fundoplication) in the treatment of GORD. Pharmacoeconomics 2007;25(10):829-41.
  • Bravo Vergal Y, Hawkins N, Claxton K, Asseburg C, Palmer S, Woolacoot N, Bruce IN, Sculpher MJ. The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology 2007;46:1729-35. Download from Oxford Journals
  • Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, De Belder M, Abrams A, Sculpher M. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart 2007;93:1238-43. Download from BMJ
  • Briggs A, Mihaylova B, Sculpher M, et al. The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 2007;93:1081-6.
  • Caraher M, Carr-Hill R. Taxation, public health and macro-social determinants: ‘sin taxes’ or structured approaches. In: Galea S, Editor. Macrosocial Determinants of Population Health 2007:211-32. 
  • Carr-Hill R. Educational services and nomadic groups. In: Dyer C, editor. The education of nomadic peoples: current issues and future prospects. Berghahn Books;2007.
  • Carr-Hill R, Dixon P. Indicators of equality and diversity: patterns of social difference associated with membership of groups identified by the categories of section 75 of the Northern Ireland Act, 2007:2007. 
  • Castelli A, Dawson D, Gravelle HStreet A. Improving the measurement of health system output growth. Health Economics. 2007;16(10):1091-107.
  • Castelli A, Dawson D, Gravelle HJacobs R, Kind P, Loveridge P, Street A, et al. A new approach to measuring health system output growth and productivity National Institute Economic Review 200 (April) 105-117;2007. Download from Sage journals Online
  • Claxton K. OFT,VBP:QED? Health Economics 2007;16:545-58. Download Wiley InterScience
  • Claxton K. The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007(0-415-35235-5).
  • Claxton K, Culyer A. Rights, responsibilities and NICE: a rejoinder to Harris. Journal of Medical Ethics 2007;33:462-4. 
  • Colbourn T, Asseburg C, Bojke L, Phillips Z, Claxton K, Ades A, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses  Health Technology Assessment 2007;11(29):1-208.
  • Colbourn T, Asseburg C, Bojke L, Philips Z, Welton N, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: Cost effectiveness and value of information analyses. British Medical Journal 2007;Sept 29;335(7621):655.
  • Cookson R, Dusheiko MHardman G. Socio-economic inequality in small area use of elective total hip replacement in the English NHS in 1991 and 2001. Journal of Health Services Research and Policy 2007;12 suppl.
  • Culyer AJ. NICE misconceptions. The Lancet September 11 2007.
  • Culyer AJ. Equity of what in health care? Why the traditional answers don't help policy - and what to do in the future. HealthcarePapers 2007;8(Sp):12-26.
  • Culyer AJ. Need - an instrumental view. In: Ashcroft R, Dawson A, Draper H, McMillan J, editors. Principles of health care ethics, 2nd Edition. Chichester:Wiley;2007;231-238.
  • Culyer AJ. When and how cancer chemotherapy should be privately funded. Oncology Exchange, 2007;6:47.
  • Culyer AJ. Merit goods and the welfare economics of coercion. In: Ver Eecke W,  editor. Anthology regarding merit goods. The unfinished ethical revolution in economic theory. West Lafayette: Purdue University Press;2007;174-200 (reprinted from Public Finance. 1971;26:546-572).
  • Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Not so… Journal of Health Service Research and Policy 2007;12:190-191. (letter: reply to G Mooney, J Coast, S Jan, D McIntyre, M Ryan and V Wiseman).
  • Culyer AJ. Resource allocation in health care: Alan Williams’ decision maker, the authority and Pareto. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams: Be Reasonable -Do it My Way! Oxford: Radcliffe Publishing; 2007. p. 57-74.
  • Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy 2007;12:56-8. 
  • Davies H, Mannion R, Jacobs R, Powell AE, Marshall MN. Does hospital organisational culture influence hospital performance. Medical Care and Research Review 2007;64(1):66-82.
  • Dawson D, Gravelle H, Jacobs R, Martin S, Smith PC. The effects of expanding choice of provider on waiting times: evidence from a policy experiment. Health Economics 2007;16(2):113-28.
  • Drummond M, Mason A. Costs and cost-effectiveness of cancer therapies: a european perspective. J Clin Oncol 2007;25(2):191-195.
  • Drummond MF. Evidence for coverage decisions: the need for a reality check. Value in Health 2007;10(5):321.
  • Drummond MF. NICE: A nightmare worth having? Health Economics, Policy and Law 2007;2(2):203-8.
  • Dusheiko M, Gravelle H, Yu N, Campbell S. The impact of budgets for gatekeeping physicians on patient satisfaction: evidence from fundholding. Journal of Health Economics 2007;26:242-62.
  • Epstein D. The health related quality of life of patients with acute coronary syndrome: a comparison of early intervention versus conservative management. Revista Espanola de Economia de la Salud 2007;6:380-5.
  • Epstein D, Chalabi Z, Claxton KSculpher M. Efficiency, equity and budgetary policies: informing decisions using mathematical programming. Medical Decision Making 2007;27:128-37. Download from Sage Journals Online
  • Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Fleurence RL, Iglesias C, Johnson JM. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature. Pharmacoeconomics 2007;25(11):913-33.
  • Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, Herrington SA, Hays RD, Kaplan RM, Ganiats TG, Feeny d, Kind P. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care 2007;45(12):1162-70.
  • Goeree R, Burke N, O'Reilly D, Manca A , Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion 2007;23(4):671-82. 
  • Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evalutations: stepping forward to optimal decision rules. Health Economics 2007;16:307-317.
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, Parker S, Roland M. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31-34. 
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, et al. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31.
  • Gravelle H, Hole A. The work hours of general practitioners' workload: survey of English GPs. British Journal of General Practice . 2007;57:96-100.
  • Gravelle H, Siciliani L. Optimal waits and charges in health insurance. February 2007; Department of Economics Discussion Paper 07/02.
  • Griffin SC, Barber JA, Manca A, Sculpher M, Thompson SG, Buxton MJ, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina. British Medical Journal 2007;334(7594):624. Download from BMJ
  • Griffin S, Claxton K, Hawkins N, Sculpher M. Decision models need to be fit for purpose for decision making: response to Caro et al. Value in Health 2007;10(4):319. Download Wiley InterScience
  • Hanratty B, Craig D, Nixon J, Rice S, Christie J, Drummond MF. Are the best available clinical effectiveness data used in economic evaluations of drug therapies? Journal of Health Services Research and Policy 2007;12:(3):138-41
  • Hauck K, Street A. Do targets matter? A comparison of English and Welsh national health priorities. Health Economics 2007;16:275-90.
  • Hicks L, Gibbs I, Weatherly H, Byford S. Managing Children's Homes. Developing effective leadership in small organisations. London: Jessica Kingsley Publications 2007. Details from Jessica Kingsley Publishers
  • Hole AR. A comparison of approaches to estimating confidence intervals for willingness to pay measures. Health Economics 2007;16:827-40.
  • Hole A. Fitting mixed logit models by using maximum simulated likelihood. Stata Journal 2007;7:388-401.
  • Jacobs R, Goddard M. How do performance indicators add up? An examination of composite indicators in public services. Public Money and Management 2007;27(2):103-110.
  • Jacobs R, Goddard M, Smith P. ‌‌‎‌‎ Policy Discussion Briefing, Centre for Health Economics, University of York; 2007.
  • Jacobs R, Goddard M, Smith PC. Are composite indicators a good measure of performance? Laria News, LARIA Newsletter, Local Authorities Research Intelligence Association 2007;83.
  • Jacobs R, Goddard M, Smith PC. Composite measures of performance: should we trust them? Performance Measurement Association Newsletter 2007;6(1):12-14
  • Kennedy A, Reeves D, Bower P, Lee V, Middleton E, Richardson G, et al. The effectiveness and cost effectiveness of a national lay led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. Journal of Epidemiology and Community Health 2007;61:254-61. 
  • Keen J, Deeming C, Moore J, Weatherly H. New labour, equity and public services: a Rawlsian perspective. Policy and Politics. 2007;35(2):197-214.
  • Kind P. Size matters: EQ-5D in transition. Medical Care 2007;45(9):809-11.
  • Manca A, Dumville J, Torgerson DJ, Klaber Moffett JA, Mooney MP, Jackson DA, et al. Randomised trail of two physiotherapy interventions for primary care back and neck pain patients: cost-effectiveness analysis. Rheumatology 2007;46:1495-1501.
  • Manca A, Lambert PC, Sculpher M, Rice N. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelling. Medical Decision Making 2007;27:471-90. Download from Sage Journals Online
  • Marini G. Non-Keynesian effects of fiscal policy: the role of rational expectations, (In Italian). Rivista Italiana di Economia demografia e Statistica 2007.
  • Marini G, Street A. A transactions costs analysis of changing contractual relations in the English NHS. Health Policy. 2007;83(1):17-26.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Foundation Trusts in the NHS: does more freedom make a difference? Health Policy Matters 2007;13:1-8.
  • Martin S, Rice NJacobs R, Smith PC. The market for elective surgery: Joint estimation of supply and demand. Journal of Health Economics 2007;26(2):263-285.
  • Mason A. The HealthBASKET Project: documenting the benefit basket and evaluating service costs in Europe. In: Curtis L, ed. Unit Costs of Health and Social Care 2007. Canterbury: University of Kent 2007:15-18. Available at http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_healthbasket.pdf
  • Mason AR, Carr-Hill R, Myers L. Rapid review of the economic evidence for community engagement and community development approaches in interventions or initiatives seeking to address wider determinants of health. Report and evidence tables. Final report for NICE Community Enagagment project; 2007.  
  • Mason A, Towse A (eds). The ideas and influence of Alan Williams. Be reasonable - do it my way!. New York: Radcliffe Publishing, Oxford. November 2007.
  • Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. The effectiveness and cost-effectiveness of respite for caregivers of frail older people: a systematic review. J Am Geriatr Soc . 2007;55(2):290-9.
  • Mason AWeatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. A systematic review of the effectiveness and cost-effectiveness of different models of community-based care for frail older people and their carers. Health Technology Assessment ; April 2007;11(15):1-176. Download from HTA
  • McCabe C, Claxton K , Tsuchiya A, Raftery J. Assessing the economics challenges posed by orphan drugs: a comment on Drummond et al. International Journal of Technology Assessment in Health Care. 2007;23:397-401.
  • McDaid C, Griffin S, Weatherly H. The Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea-Hypopnoea Syndrome: a Systematic Review and Economic Analysis: Assessment report for the National Institute for Health and Clinical Excellance; September 2007.  
  • Olry de Labry Lima A, Epstein D, Garcia Mochon L, et al. Comparacion de costes y supervivencia en pacientes intervenidos quirurgicamente de cancer colorrectal segun diferentes modelos organizativos. Rev Esp Enfirm Dig. 2007;99(11):643-7.
  • Ossa DF, Briggs A, McIntosh E, Cowell W, Littlewood T, Sculpher M. Recombinant erythropoietin for chemotherapy-related anaemia. Pharmacoeconomics 2007;25:223-37.
  • Preker AS, Xingzhu L, Velenyi EV, Baris E. Public ends, private means: strategic purchasing of health services. Washington D.C: The World Bank; 2007.
  • Robson LS, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvin E, Culyer AJ,  Mahood Q. The effectiveness of occupational health and safety management system interventions: A systematic review. Safety Science 2007;45:329-53.
  • Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytical cost-effectiveness models: a suggested framework and example of application. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Siciliani L. Optimal contracts for health services in the presence of waiting times and asymmetric information. The BE Journal of Economic Analysis & Policy Contributions 2007;7(1):article 40.
  • Siciliani L, Martin S. An empirical analysis of the impact of choice on waiting times. Health Economics 2007;16(8):763-79.
  • Spilsbury K, Nelson A, Cullum N, Iglesias C, Nixon J, Mason S. Pressure ulcers and their treatment and effects on quality of life: hospital inpatient perspectives. Journal of Advanced Nursing 2007;Mar 57(5):494-504.
  • Street A. Does information technology improve the productivity of the health care system? Revista Espanola de Economia de la Salud. 2007;6(5):282-6. 
  • Street A. Should GPs hold budgets to purchase hospital services? Revista Espanola de Economia de la Salud. 2007;6(2):88-92.
  • Street A. The contribution of ICT to health care system productivity and efficiency: what do we know? Organisation for Economic and Community Development, Paris. March 2007.
  • Street A, Maynard A. Activity Based Financing in England: the Need for continual Refinement of Payment by Results. Health Economics, Policy and Law 2007;2(4):419-27. Download from Cambridge journals‌‌‎
  • Street A, Maynard A. Payment by results (PDF , 41kb)‌‌‎‌‎ : qualified ambition? Health Economics, Policy and Law 2007;2(4):445-8. 
  • Street A, Miraldo M. The impact of the reform of hospital funding in England (PDF , 246kb)‌‌‎‌‎ . Paper presented at: Evaluating Health Policy: New Evidence from administrative Data. University of York 2007.
  • Suresh Punekar Y, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients health status: a western view Respiratory Medicine 2007;101:661-69. Download from Elsevier
  • Walker S, Palmer S, Sculpher M. The role of NICE technology appraisal in NHS rationing.British Medical Bulletin 2007:1-14.Download from Oxford Journals

2006

  • Ades A, Claxton KSculpher M. Evidence synthesis, parameter correlation and probablistic sensitivity analysis. Health Economics 2006;15:373-82. Download from Wiley InterScience
  • Ades AE, Sculpher MJ, Sutton A, Abrams A, Cooper N, Welton N, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006;24:2-29.
  • Baker R, Thompson C, Mannion R. Q-methodology in health economics. Journal of Health Services Research and Policy 2006;11(1):38-45.
  • Boaden R, Dusheiko M, Gravelle H, Parker S, Pickard S, Roland M, et al. Evercare Evaluation Final Report. National Primary Care Research and Development Centre, University of Manchester; November 2006. Download from NPCRDC 
  • Bravo Vergel Y, Chilcott J, Kaltenthaler E, Walters SJ, Blakeborough A, Thomas S. ‌‌ compared to endoscopic retrograde cholaniopancreatography for the investigation of biliary tree obstruction. International Journal of Surgery 2006;4(1):12-19.  
  • Bravo Vergel Y, Ferguson B. Difficult commissioning choices. A proposed framework for priority setting and a comparative analysis of rationing policies across West Yorkshire & NEYNL PCTs. Journal of Health Services Research and Policy 2006;11(3):150-155.  
  • Bravo Vergel YSculpher M. Making decisions under uncertainty– The role of probabilistic decision modeling. Family Practice 2006;23(4):391-392.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press 2006. Download from OUP
  • Busse R, Schreyögg J, Smith PC. Editors and editorial for Special issue on hospital case payment systems in Europe. Health Care Management Science 2006;9(3):211-3.
  • Claxton K, Culyer AJ. Wickedness or folly? The ethics of NICE’s decisions. Journal of Medical Ethics 2006;32: 373-377. 
  • Claxton K, Culyer AJ, Sculpher M, McCabe C, Briggs A, Akehurst R, Brazier J, Buxton M. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion (Editorial). Health Economics 2006;15:1-4.
  • Claxton K, Sculpher M. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006;24:1055-68.
  • Claxton K, Sculpher M, Fenwick E. Decision making with uncertainty. In: Jones AM, editor. Companion to Health Economics: Edward Elgar; 2006.
  • Cookson R, Dawson D. Hospital Competition and Patient Choice in Publically Funded Health Care. In: Jones AM, editor. The Elgar Companion to Health Economics. Part IV, Chapter 20. Cheltenham: Edward Elgar; 2006.
  • Culyer AJ. NICE's use of cost-effectiveness as an exemplar of a deliberative process. Health Economics, Policy and Law. 2006;1:299-318.
  • Culyer AJ. Paying for performance: neither the end of the beginning nor the beginning of the end. HealthcarePapers 2006;6:34-8.
  • Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, 4 Vols., Abingdon:Routledge, 2006 (Vol. 1, pp. xxvi + 545; Vol. 2, pp,. xi + 450; Vol. 3, pp. viii + 386; Vol. 4, pp. xi + 600).
  • Culyer AJ. Evidence, economics and values in coverage decisions. In Morgan S. Editor. Toward a national pharmaceuticals strategy. Vancouver: Centre for Health Services and Policy Research UBC. 2006;10-11.
  • Culyer AJ. The bogus conflict between efficiency and equity. Health Economics 2006; 15:1155-1158(Editorial).
  • Culyer AJ. Welfarism vs.Extra-Welfarism. Köz-Gazdaság Tudományos Füzetek (Public Economics Science Journal) 2006;1:89-101.
  • Culyer AJ. The nature of the commodity 'health care' and its efficient allocation. In Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, London: Routledge. 2006; 324-346 (reprinted from Oxford Economic Papers, 1971;23: 189-211).
  • Culyer AJ. The normative economics of health care finance and provision. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge, 2006;347-384. (reprinted from A. McGuire, P. Fenn and K. Mayhew (eds.) Providing health care: the economics of alternative systems of finance and delivery, Oxford: Oxford University Press. 1991;34-58).
  • Culyer AJ, Evans RG. Mark Pauly on welfare economics: normative rabbits from positive hats. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge. 2006;148-157 (reprinted from Journal of Health Economics. 1996;15: 243-251).
  • Culyer AJ, Lomas J. Deliberative processes and evidence-informed decision-making in health care – do they work and how might we know?  Evidence and Policy 2006;2: 357-371.
  • Culyer AJ, Saltman R. Privatization – assessing strategies in a central Asian republic. In: Zöllner H, Stoddart G, Selby Smith V. editors Learning to live with health economics, Copenhagen: WHO. 2006; III-95 - III-105 (copyrighted 2003, published 2006).
  • Culyer AJ, Wagstaff A. Equity and equality in health and health care. In: Culyer AJ  Editor: Health economics: critical perspectives on the world economy, London: Routledge. 2006;483-509. (reprinted from Journal of Health Economics. 1993;12:431-457).
  • Dawson D, Jacobs R, Martin S, Smith PC. The impact of patient choice and waiting time on the demand for health care: Results from the London Patient Choice Project. Applied Economics 2006;38:1363-70.
  • Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Family practice performance in the first year of the UK's new 'pay for performance' scheme: good clinical practice or gaming? New England Journal of Medicine. 2006;355:375-84.
  • Dumville J, Manca A, Kitchener H, Smith R, Nelson L, Torgerson D. On behalf of the COLPO study group. Cost-effectiveness analysis of open colposuspension versus laparoscopic colposuspension in the treatment of urodynamic stress incontinence. BJOG: An International Journal of Obstetrics and Gynaecology 2006;113:1014-22. Download from Wiley InterScience
  • Dusheiko M, Gravelle HJacobs R, Smith PC. The effect of financial incentives on gatekeeping doctors: evidence from a natural experiment. Journal of Health Economics 2006;25(3):449-478.
  • Drummond M, Mason A, Towse A. The desirability and feasibility of economic studies post-launch. European Journal of Health Economics. March 2006 1(7):5-6.
  • Drummond MSculpher M, Better analysis for better decisions: has pharmoeconomics come of age? Pharmacoeconomics 2006;24:107-108. 
  • Drummond M, Sculpher M. Better analysis for better decisions: facing up to the challenges. Pharmacoeconomics. 2006;24:1039-42. 
  • English M, Lanata CF, Ngugi I, Smith PC. The District hospital. In: Jamison DT, editor. Disease control priorities in developing countries. Oxford: Oxford University Press; 2006.
  • Epstein D, Mason A. Costs and prices for inpatient care in England: mirror twins or distant cousins? Health Care Management Science 2006 August;9(3):233-42.
  • Fenwick E, Palmer SClaxton KSculpher M, Abrams K, Sutton A. An iterative Bayesian approach to Health Technology Assessment: application to a policy of preoperative optimisation for patients undergoing major elective surgery. Medical Decision Making 2006;26:480-96. Download from Sage Journals Online 
  • Goddard M, Hauck K, Preker A, Smith PC. Priority setting in health - a political economy perspective. Health Economics, Policy and Law 2006;1(1):79-90.
  • Goddard MMannion R. Decentralising the NHS: rhetoric, reality and paradox. Journal of Health, Organisation and Managment 2006;20(1):67-73.
  • Gravelle H, Morris S, Sutton M. Economic Studies of equity in the consumption of health care. In: Jones AM, editor. Elgar Companion to Health Economics: Edward Elgar; 2006. p. 193-204. 
  • Gravelle H, Morris S, Sutton M. Economic Studies of equity in the consumption of health care. In: Jones AM, editor. Elgar Companion to Health Economics: Edward Elgar; 2006. p. 193-204. 
  • Gravelle H, Rees R. Microeconomics: Solutions Manual and Workbook. London: Prentice Hall; 2006.
  • Gravelle H, Siciliani L. Is waiting time prioritisation welfare improving? Department of Economics Discussion Paper. 2006;06/13.
  • Griffin S, Bojke L, Main C, Palmer S. Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer. Value in Health. 2006;9(2):123-31. Download from Wiley InterScience
  • Griffin SClaxton K, Hawkins N, Sculpher MJ   (2006). Probabilistic analysis and computationally expensive models: necessary and required? Value in Health 2006;9(4):244-252. Download from Wiley InterScience
  • Hauck K, Street A. Performance assessment in the context of multiple objectives: a multivariate multilevel analysis. J Health Econ. 2006;25:1029-48.
  • Hole AR. Calculating Murphy-Topel variance estimates in Stata: a simplified procedure. Stata Journal
  • Hole AR. Small-sample properties of tests for heteroscedasticity in the conditional logit model. Economics Bulletin.
  • Hollingsworth B, Street A. The market for efficiency analysis of health care organisations. Health Economics. 2006;15:1055-9.
  • Jacobs R, Martin S, Goddard M, Gravelle H, Smith PC. Exploring the determinants of NHS performance ratings: lessons for performance assessment systems. Journal of Health Services Research and Policy. 2006;11(4):211-7.    
  •  Jacobs RSmith PCGoddard M. The development of composite indicators to measure performance in health care. In: Neely A, editor. Performance Measurement: Theory and Practice. Cambridge: Cambridge University Press; 2006.
  • Jacobs R, Smith PC and Street A . Measuring efficiency in health care: analytic techniques and health policy: Cambridge University Press June 2006. Details here 
  • King S, Griffin S, Hodges Z, Weatherly HAsseburg C, Rchardson G, et al. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Wincheste, England: Health Technology Assesment 2006:10(23);iii+146    
  • Main C, Ginnelly L, Griffin S, Norman G, Barbieri M, Mather L, et al. A systematic review of the clinical effectiveness and cost effectiveness of topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer (update). Health Technology Assessment 2006:10(9). 
  • Manca A, Epstein D, Torgerson D, Klaber Moffett J, Coulton S, Farrin A, et al. Randomised trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: a cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 2006;22(1):67-75.
  • Manca A, Willan A. "Lost in translation": accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics. 2006;24(11):1101-19.
  • Mannion R, Marini G, Street A. Demand Management and adminstrative costs under payment by results. Health Policy Matters 2006;12:1-8.
  • Mason J, Mason A.  The generalisability of pharmacoeconomic studies: issues and challenges ahead. Pharmacoeconomics 2006; 24(10): 937-945.
  • Mason ADrummond M, Towse A. Economic post-launch studies: matching the desirable with the feasible. London: Office of Health Economics; 2006 September.
  • Mason A, Smith PC. Regulation and relations between the different participants in the English health care system. Revue Française des Affaires Sociales 2006 September;2:265-84.
  • Mason A, Street A. Publishing outcomes data: is it an effective approach? Journal of Evaluation in Clinical Practice 2006;12(1):37-48.
  • Mason A, Smith P. Le systeme de sante anglais: regulation et papports entre les differents acteurs. Revue Francaise des Affaires Sociales. 2006;16(2/3):265-84.
  • Maynard A, Street A. Seven years of feast, seven years of famine: from boom to bust in the NHS. British Medical Journal 2006;332:906-8. http://bmj.bmjjournals.com/cgi/reprint/332/7546/906 
  • McCabe C, Claxton K, Tsuchiya A, Raftery J. Orphan drugs revisited. Quarterly Journal of Medicine 2006; 99:341-345. Download from Oxford Journals 
  • Nelson E, O'Meara S, Craig D, Iglesias C, Golder S, Dalton J, Claxton K. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technology Assessment 2006;10(12):1-238. 
  • Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C. DASIDU Steering Group. Systematic review of antimicrobial treatments for diabetic foot ulcers Diabet Med 2006;Apr;23(4) 348-59. 
  • Nixon J, Nelson EA, Cranny G, Iglesias CP, Hawkins K, Cullum N, Phillips A, Spilsbury K, Torgerson DJ, Mason S. PRESSURE Trial Group. Pressure relieving support surfaces: a randomised evaluation. Health Technology Assessment 2006 Jul;10(22):iii-iv, ix-x, 1-163. 
  • Nixon J, Cranny G, Iglesias C, Nelson EA, Hawkins K, Phillips A, Torgerson DJ, Mason S, Cullum N. Randomised, controlled trial of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressure relieving support surfaces) trial. BMJ 2006 Jun 17;332(7555):1413. 
  • Olsen KR, Street A, Svenning AR, Hvenegaard A, Sogaard J. Usikkerhed forbundet med opgorelse af relativ produktivitet i sygehussektoren. Nationalokonomisk Tidsskrift 2006;144:353-61.
  • O'Meara S, Nelson EA, Golder S, Dalton J, Craig D, Iglesias C. DASIDU Steering Group. Systematic review of methods to diagnose infection in foot ulcers in diabetes Diabet Med 2006;Apr;23(4) 341-47.
  • Petherick ES, O'Meara S, Spilsbury K, Iglesias CP, Nelson EA, Torgerson DJ. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial. BMC Med Res Methodol 2006;Sep 1:6:43.
  • Philips Z, Bojke LSculpher MClaxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality of assessment. Pharmacoeconomics 2006;24:355-71.
  • Philips Z, Claxton KP, Palmer S, Bojke L, Sculpher MJ. Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Health Care 2006;22(3):379-387. Download from Cambridge Journals.  
  • Review of Citizens’ Councils and Recommendations for the Creation of a Citizens’ Council in Ontario as Mandated under the Transparent Drug System for Patients Act, University of Toronto Priority Setting in Health Care Research Group (Culyer AJ  with Andreas Laupacis, Doug Martin, Alan Hudson, Wendy Levinson, Terrence Sullivan,  Bill Evans, Steven Pearson, Irfan Dhalla, Tasha Jeyanathan) 2006.
  • Richardson GHawkins N, McCarthy JC, Mills PM, Pullen R, Roberts C, et al. Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. International Journal of Technology Assessment in Health Care 2006;22(1):84-89. 
  • Richardson G, Sculpher M, Kennedy A, Nelson E, Reeves D, Roberts C, et al. Is self-care a cost-effective use of resources? evidence from a randomised trial in inflammatory bowel disease. Journal of Health Services Research and Policy 2006;11(4):225-30. 
  • Scott A, Gravelle H, Simeon S, Sibbald B, Bojke C. Job satisfaction and quitting intentions: a structural model of British general practitioners British Journal of Industrial Relations 2006;44:519-40. 
  • Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making. Health Economics, 2006;15:677-687. Download Wiley InterScience
  • Sculpher MJ, Drummond MF. Analysis sans frontiers: can we ever make economic evaluations generalisable across jurisdictions? Pharmacoeconomics. 2006;24(11):1087-99.
  • Sheaff R, Schofield J, Mannion R, Marshall M, McNally R, Dowling B. Achieving high performance in health care systems: the impact and influence of organisational arrangements, Studying Health Care Organisations Briefing Paper. London: NHSSDO; 2006.
  • Smith PC. Formula Funding of Public Services. London: Routledge; 2006.
  • Smith PC. The future role of user charges in the National Health Service.  House of Commons Health Committee, NHS Charges: Volume III. London: The Stationery Office; 2006. p. 155-8.
  • Smith PC. User charges for health care: history and prospects. In: Asato J, editor. Charging ahead? Spreading the costs of modern public services. London: Social Market Foundation; 2006.
  • Smith PC. Public packages of health care alongside voluntary insurance. In: Preker A, Scheffler RM, Bassett M, editors. Private voluntary health insurance in development: friend or foe? Washington DC: World Bank; 2006.
  • Smith PC. Quantitative approaches towards assessing organizational performance. In: Boyne GA, editor. Public service performance: perspectives on measurement and management. Cambridge: Cambridge University Press; 2006.
  • Smith PCStreet A. Analysis of secondary school efficiency, Research Report 788. Department for Education and Skills. London 2006. Download here
  • Smith PC, Street A. Concepts and challenges in measuring the performance of health care organisations. In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar; 2006.
  • Stoltzfus Jost T, Dawson D, den Exter A. The role of competition in health care: a Western European perspective. Journal of Health Politics, Policy and Law 2006;31(3):687-703.
  • Street A. The future of quality measurement in the NHS. Expert Reviews of Pharmacoeconomics and Outcomes Research. 2006;6(3):245-8. Paper available to download here
  • Street A. Reforma de la financicion hospitalaria e introduccion de mecanismos de eleccion en el sistema sanitario britanico NHS. Revista Espanola de Economia de la Salud.2006;5(2):97-102. Paper available to download here. English version, Reform of hospital funding and the introduction of patient choice in England . Paper available to download here
  • Street A, Castelli A, Dawson D, Gravelle H. Retos en le medición y valoración de los rendimientos del sistema de salud [Challenges in measuring and valuing health service output]. Revista Española de Economía de la Salud, 2006;5(6)335-360.
  • Street A, Castelli A, Dawson D, Gravelle H, (on behalf of CHE/NIESR productivity project research team). Challenges in measuring and valuing health service output. Revista Espanola de Economi e la Salud 2006;5(6):335-342.
  • Szende A, Culyer AJ.  The inequity of informal payments for health care: the case of Hungary. Health Policy. 2006;75:262-271.
  • Urdahl H, Manca A, Sculpher M. Assessing generalisability in model-based economic evaluation studies. A structured review in osteoporosis. Pharmacoeconomics. 2006;24(12):1181-97. Download from Ingenta Connect 
  • Wearden AJ, Riste L, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Dunn G, Richardson G, Powell P. Fatigue intervention by nurses evaluation - The FINE trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome. Biomed Central Medicine. 2006;4(9). Download from BMC 
  • Weighing up the evidence: making evidence-informed guidance accurate, achievable, and acceptable, (Culyer AJ  Convenor with Jonathan Lomas) 2006, Ottawa: Canadian Health Services Research Foundation,14 pp.
  • Whalley D, Bojke C, Gravelle H, Sibbald B. Morale of the GP workforce in the light of reform: a national survey of job satisfaction. British Journal of General Practice 2006;56:87-92.
  • Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, Watt I, Glanville J, Sculpher M, Kleijnen J. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technology Assessment 2006;10(36).
  • Williams J, Russell I, Durai D, Cheung W-Y, Farrin A, Bloor K, Coulton S, Richardson G. What are the clinical outcomes and cost-effectivenss of endoscopy undertaken by nurses when compared with doctors? A multi institution nurse endoscopy trial (MINuET). Health Technology Assessment 2006;10(40). Download from HTA 
  • Woolacott N, Bravo Vergel YHawkins N, Khadjesari Z, Kaith A, Misso K, Light K, Asseburg C, Palmer SClaxton K, Chalmers R, Bruce I, Sculpher M, Riemsma R Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2006; 10(31):1-258.
  • Woolacoot N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Bravo Vergel Y, Misso K, Light K, Chalmers R,Sculpher M, Riemsma R. Etanercept and Efalizumab for the treatment of psoriasis: a systematic review. Health Technology Assessment 2006; 10(46):1-252.